Medicines and Poisons Amendment Regulations 2020 (WA)

6 November 2020 GOVERNMENT GAZETTE, WA 4135

HE302

Medicines and Poisons Act 2014

Medicines and Poisons Amendment

Regulations 2020

SL 2020/214

Made by the Governor in Executive Council.

1.             Citation

These regulations are the Medicines and Poisons Amendment
Regulations 2020.

2.             Commencement

These regulations come into operation as follows —

(a) regulations 1 and 2 — on the day on which these

regulations are published in the Gazette;

(b) the rest of the regulations — on the day after that day.

3.             Regulations amended

These regulations amend the Medicines and Poisons
Regulations 2016.

4.             Regulation 142 amended

In regulation 142(3) delete “record” and insert:

information recorded under subregulation (2)

5.             Regulation 143 amended

In regulation 143(2) delete “record” and insert:

information recorded under subregulation (1)

6.             Regulation 143A inserted

After regulation 143 insert:

143A.	Record of prescription of medicine that is Schedule 4 or 8 poison
(1)	An authorised health professional who prescribes a medicine that is a Schedule 4 or 8 poison for the

4136 GOVERNMENT GAZETTE, WA 6 November 2020

treatment of a person or an animal must ensure that the following information is recorded on the clinical record

for the person or animal —

(a)	the name and address of the authorised health professional;
(b)	the name, quantity, strength and form of the medicine prescribed;
(c)	if the medicine is prescribed for the treatment

of a person —

(i)      the name and address of the person; and

(ii)      if the medicine is a Schedule 8

poison — the date of birth of the person;

(d) if the medicine is prescribed for the treatment

of an animal —

(i)      the name and address of the owner of the animal; and

(ii)      the species of the animal;

(e) the date on which the medicine is prescribed.

(2)	The information recorded under subregulation (1)
must —

(a)	be provided to the CEO in the manner and form and at the times specified by the CEO; and
(b)	in the case of a medicine that is a Schedule 4

poison — be kept for at least 2 years from the

date on which the medicine is prescribed; and

(c) in the case of a medicine that is a Schedule 8

poison — be kept for at least 5 years from the

date on which the medicine is prescribed; and

(d) be produced for inspection on the request of the CEO or an investigator.

7.             Schedule 2 amended

In Schedule 2 insert in alphabetical order:

N-[(1S)-1-(AMINOCARBONYL)-2-METHYLPROPYL]-1-(5-FLUORO

PENTYL)-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE

(5F-AB-P7AICA)

1-BUTYL-N-(2-PHENYLPROPAN-2-YL)-1H-INDOLE-3-CARBOXA

MIDE (CUMYL-BICA)

1-(4-CYANOBUTYL)-N-(1-METHYL-1-PHENYLETHYL)-1H-INDAZ
OLE-3-CARBOXAMIDE (SGT-78; 4-CN-CUMYL-BINACA;

CUMYL-CB-PINACA; CUMYL-CYBINACA; 4-CYANO

CUMYL-BUTINACA)

6 November 2020 GOVERNMENT GAZETTE, WA 4137

1-CYCLOHEXYL-4-(1,2-DIPHENYLETHYL)PIPERAZINE (MT-45;

IC-6)

2,5-DIHYDRO-2-(1-METHYL-1-PHENYLETHYL)-5-PENTYL-1H-PY

RIDO[4,3-B]INDOL-1-ONE (CUMYL-PEGACLONE; SGT-151)

5-(5-FLUOROPENTYL)-2-(2-PHENYLPROPAN-2-YL)-2,5-DIHYDRO

-1H-PYRIDO[4,3-B]INDOL-1-ONE (5F-CUMYL-PEGACLONE; 5F

SGT-151)

2-(2-FLUOROPHENYL)-2-METHYLAMINO-CYCLOHEXANONE

(2-FLUORODESCHLOROKETAMINE; 2FDCK)

METHYL

2-(9-(CYCLOHEXYLMETHYL)-9H-CARBAZOLE-3-CARBOXAMID

O)-3,3-DIMETHYLBUTANOATE (MDMB-CHMCZCA)

METHYL

2-[1-(4-FLUOROBENZYL)-1H-INDOLE-3-CARBOXAMIDO]-3-MET

HYLBUTANOATE (MMB-FUBICA; AMB-FUBICA)

METHYL
2-[[1-(4-FLUOROBUTYL)INDAZOLE-3-CARBONYL]AMINO]-3,3-DI

METHYL-BUTANOATE (4F-MDMB-BINACA;

4F-MDMB-BUTINACA)

METHYL
2-[[1-(5-FLUOROPENTYL)INDOLE-3-CARBONYL]AMINO]-3,3-DI

METHYL-BUTANOATE (5-FLUORO MDMB-PICA;

5F-MDMB-PICA)

N-METHYL-1-(THIOPHEN-2-YL)PROPAN-2-AMINE

(METHIOPROPAMINE; MPA)

N-(1-NAPHTHYL)-1-(5-FLUOROPENTYL)-1H-INDOLE-3-CARBOX

AMIDE (5F-NNEI; 5F-MN-24)

M. INGLIS, Clerk of the Executive Council.

———————————